Back to Search
GREGORY MASTERS, MD
MD
Orthopaedic Surgery Physician
NPI: 1689750515Individual
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
A74016(CA)
Research & Publications (20)
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).
PMID 17409935·J Thorac Oncol·2006
3-trial
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
PMID 17409822·J Thorac Oncol·2006
3-trial
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.
PMID 12697880·J Clin Oncol·2003
3-trial
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors.
PMID 12665678·Med Oncol·2003
3-trial
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
PMID 12581577·Lung Cancer·2003
3-trial
Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study.
PMID 11181999·Oncologist·2001
3-trial
Gemcitabine and carboplatin in advanced non small-cell lung cancer: a review.
PMID 14725730·Clin Lung Cancer·2000
8-other
Incidence of haemoglobinopathies in various populations - the impact of immigration.
PMID 19497317·Clin Biochem·2009
8-other
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
PMID 19096313·J Thorac Oncol·2009
3-trial
Expenditure on diabetes treatments and achievement of glycaemic control: retrospective analysis.
PMID 18544110·Diabet Med·2008
4-observational
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
PMID 18758305·J Thorac Oncol·2008
3-trial
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
PMID 18281656·J Clin Oncol·2008
3-trial
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
PMID 18281659·J Clin Oncol·2008
3-trial
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.
PMID 18282359·Clin Lung Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 710 LAWRENCE EXPY
SANTA CLARA, CA 95051 - Phone
- (408) 236-6400
Quick Facts
- NPI
- 1689750515
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile